Moderna claims that its new vaccine for respiratory syncytial virus is effective in older adults, according to a Jan. 17 report from CNBC.
Moderna claims that its new vaccine for respiratory syncytial virus is effective in older adults, according to a Jan. 17 report from CNBC.